Diovan HCT Paragraph IV Certification Filed
The first ANDA with a Paragraph IV certification for Novartis' antihypertensive Diovan HCT (valsartan and hydrochlorothiazide) was filed Dec. 2, according to FDA's Feb. 6 updated list of filings
The first ANDA with a Paragraph IV certification for Novartis' antihypertensive Diovan HCT (valsartan and hydrochlorothiazide) was filed Dec. 2, according to FDA's Feb. 6 updated list of filings